NAS10029,644+0.67%S&P7,651+0.17%GOLD$4,417−0.18%BTC$81,133−0.12%VIX14.81−4.08%live tape · as of 23:00 UTC · 20 Sep
The Screen · Industrials · Specialty Industrial Machinery
Parker Hannifin
PH · a US exchange · USD · Market cap $120.5B · 57,950 employees
Parker-Hannifin Corporation manufactures and sells motion and control technologies and systems for aerospace and defense, in-plant and industrial equipment, transportation, off-highway, energy, and HVAC and refrigeration…
Positioning political selling, disclosed 2026-08-11
Options no verdict drawn today, left as found
Ethical passes the values gate
Price955.87 USD
Fair value998.60
Ethical score85.1/100
RatingOVERVALUED
Our investment reviews on this name
2026-09-06Read Markdown1,000.13-4.4% to today ✓
2026-07-30Read Markup987.54-3.2% to today
2026-07-18Read Distribution882.34+8.3% to today
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Parker Hannifin holds its Markdown at $955.87. The statistical read favours the sellers, held for 136 days.
As held on the ledger · 2026-09-08
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 136 days
Price at the screen
$955.87
Valuation
33.55 trailing · 24.41 forward price to earnings
Values screen
PASS· score 85.1
Beta
1.12
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
31.48%
Below 33%
Interest-bearing debt is just 31.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
11.45%
Below 49%
Money owed to the company is 11.4% of assets, under the 49% limit.
Pass
Revenue purity
0.06%
Below 5%
Only 0.1% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads OVERVALUED: it trades at roughly a 5% discount to our $998.60 fair value, moderate competitive moat, 9.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 4.5% margin of safety to the base estimate.
Third-party analyst targets: 23 covering, consensus Buy. The average target sits +27% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Precision Engineering in a High-Tech World
Imagine the intricate dance of robotics and machinery, where Parker Hannifin provides the choreography. This company manufactures motion and control technologies, a vital backbone for industries ranging from aerospace to energy. Its products enable the smooth operation of complex systems, which is why it stands out. With a forward P/E of 25.3x, robust revenue growth of 10%, and a healthy profit margin of 17%, Parker Hannifin is performing well, but our fair value and the current market price align at approximately $1000, indicating the market is pricing it correctly.
However, despite these positive financials, the stock is rated as OVERVALUED, suggesting that the current price may already reflect future optimism. This valuation is backed by a moderate moat, indicating that while Parker Hannifin has some competitive advantages, they may not be insurmountable. The consensus among 23 analysts is a buy, with a median target price of $1214, but this target could be ambitious given our assessment.
Risks for Parker Hannifin include the cyclical nature of its industrial markets and the potential for economic downturns to impact demand. Additionally, a MODERATE ethical pass reflects that while the company meets our standards, there may be room for improvement. This analysis should be considered in the context of the company's performance and the broader market conditions.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PH trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034.
2026-08-06Markup$996.90+0.9%Entry 11
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-05Markup$987.54+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-04Markup$987.54+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-03Markup$987.54+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-02Markup$987.54+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-01Markup$987.54+0.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-31Markup$987.54+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-30Markup · changed$987.54+11.9%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Distribution$882.34+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.